Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
(19 Aug 2025)

Back
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled 'Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)'.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew